Kalkine has a fully transformed New Avatar.
Encouraging Preclinical Results:Previous studies showed a 42% neuroprotective effect in stroke models and an 86% cardioprotective effect in heart disease research.
CoStar’s Takeover Proposal:The US real estate giant has increased its bid to AU$4.43 per share.
CHESS Breakdown Impact:December’s settlement failure led to trade settlement deferrals, prompting a downgrade of ASX’s compliance rating.
Mining and Banking Sectors Struggle:Miners fell 2% due to declining iron ore prices, while major banks lost up to 2%.
Highlights
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine! Start Your 7-Days Free Trial Today!
Continue
AU
CA
NZ
UK
US
IND
Please wait processing your request...